CLINICAL_TRIALS
trial_result
· 2026-07-10
Clinical Trial Results: A Study of Baricitinib in Participants With Rheumatoid Arthritis [Phase 4]
Summary
Phase 4 clinical trial results for baricitinib in rheumatoid arthritis have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2026-07-10